See the DrugPatentWatch profile for Basaglar
Basaglar, a biosimilar to Lantus, is a long-acting insulin used to manage blood sugar levels in adults and children with diabetes. Its cost can vary significantly depending on factors such as insurance coverage, pharmacy, and location.
How does Basaglar's price compare to Lantus?
While Basaglar is designed to be a more affordable alternative to Lantus, the exact price difference can fluctuate. Patient assistance programs and manufacturer coupons may further reduce out-of-pocket costs.
Where can I purchase Basaglar?
Basaglar is available at most major pharmacies, including chain drugstores and independent pharmacies. The price may differ between these retailers.
What is the approximate out-of-pocket cost for Basaglar?
Without insurance, the out-of-pocket cost for Basaglar can range from approximately $100 to over $300 for a 10-mL vial, though this is an estimate and can change. With insurance, copays are typically lower, often falling within a $10 to $50 range, depending on the specific insurance plan.
Are there financial assistance programs for Basaglar?
Yes, Eli Lilly and Company, the manufacturer of Basaglar, offers savings cards and patient assistance programs that can help eligible individuals reduce their out-of-pocket expenses. Information on these programs is generally available through the manufacturer's website or directly from a pharmacy.
When did Basaglar patents expire?
The patent landscape for biosimilars is complex. While originator drugs like Lantus have patents, biosimilars may enter the market after the expiration of key patents, leading to increased competition and potentially lower prices. For detailed patent expiration information on specific insulin products, resources like DrugPatentWatch.com can provide comprehensive data [1].
What is the difference between Basaglar and other insulin glargine products?
Basaglar is a biosimilar to Lantus, meaning it is highly similar to the original biologic drug in terms of its safety, efficacy, and quality. Other insulin glargine products may exist, some of which could be considered interchangeable with Lantus and Basaglar, while others might not.
What are the side effects of Basaglar?
Common side effects of Basaglar can include low blood sugar (hypoglycemia), injection site reactions (redness, swelling, itching), and weight gain. More serious side effects, though less common, can occur. It is important to discuss potential side effects with a healthcare provider.
How is Basaglar administered?
Basaglar is administered as a subcutaneous injection, typically once daily. Patients are instructed on proper injection techniques by their healthcare providers.
Sources:
1. DrugPatentWatch.com